Latest Commercial Operations News

Cobalt Blue has signed a non-binding term sheet with Swiss trader STG Metals for cobalt metal from its proposed Kwinana refinery. The proposed deal covers up to 1,000 tonnes a year, but construction, product qualification and a definitive agreement remain outstanding.

Weebit Nano has begun silicon validation with a second customer whose chip is running software from integrated ReRAM, marking another step towards potential production in 2027. The company also added two AI customers, advanced qualification work and ended the quarter with A$164.2 million in cash.

Energy Fuels has amended its proposed acquisition of VAC after a customer dispute escalated into arbitration and lender forbearance at VAC’s US magnet plant. The filing also reveals VAC’s six-month net loss of €57.4 million, substantial debt and reliance on shareholder support ahead of the proposed transaction.

Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.

Mesoblast has reported a sharp commercial step-up in FY2026, with Ryoncil generating US$115.2 million in net sales and total revenue reaching US$120.3 million. The company has also completed treatment in its 350-patient back-pain trial and refinanced its debt, but remains loss-making and expects to need more capital beyond the next 12 months.

Cobre has lifted its interest in the Sierra Atacama copper project to 62.86% after exercising a control option for approximately US$12 million. The move gives its Chilean subsidiary majority board representation as expansion, satellite pits and exploration plans advance.

LGI Limited (ASX:LGI) is buying two operating Queensland solar farms for $22 million, adding 42MW of export capacity at a price below the company’s stated greenfield replacement cost. The transaction lifts LGI’s targeted medium-term renewable and dispatchable capacity pipeline beyond 120MW, although the projected earnings contribution depends on electricity prices, synergies and software integration.

Brazilian Critical Minerals has signed binding agreements to acquire 90% of a Brazilian magnesium sulphate producer, aiming to secure a key input for its Ema rare earth project. The strategy offers greater supply-chain control, but the plant requires restructuring and carries estimated legacy liabilities of R$15.3 million.

Antimony Resources has moved closer to first production in Mexico, but its FY2026 annual report carries a material going-concern warning after a A$7.0 million loss and sharply reduced cash reserves. The company now faces the harder test of turning its Tecomatlán plant and Los Lirios project into cash-generating operations.

Quantum Graphite has moved Uley 2 into front-end engineering and design, renewed key mining leases and formalised its downstream structure with Sunlands Pure Group. But the company ended FY2026 with just $210,710 in cash, $10.50 million in borrowings and an auditor-documented material uncertainty over its ability to continue as a going concern.

Mount Ridley Mines has used its FY2026 annual report to put scale and processing progress at the centre of its Grass Patch story, including a post-year-end scandium resource upgrade to 946.1 million tonnes. The company remains loss-making and pre-production, but September testwork reported approximately 92% scandium recovery and average heavy rare earth recovery of about 84%.

Clarity Pharmaceuticals is approaching pivotal Phase III readouts for its prostate cancer imaging agent, backed by AUD178.3 million in liquid assets. The radiopharmaceutical developer remains deeply loss-making, but expanded manufacturing capacity and early clinical signals are pulling its commercial ambitions into sharper focus.